Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques-Reference-Cited by-同舟云学术

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques

Published:2021-09-10 Issue:37 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Bewley Kevin R.¹^ORCID,Gooch Karen¹,Thomas Kelly M.¹^ORCID,Longet Stephanie¹,Wiblin Nathan¹,Hunter Laura¹,Chan Kin¹,Brown Phillip¹^ORCID,Russell Rebecca A.²^ORCID,Ho Catherine¹,Slack Gillian¹,Humphries Holly E.¹^ORCID,Alden Leonie¹,Allen Lauren¹^ORCID,Aram Marilyn¹^ORCID,Baker Natalie¹,Brunt Emily¹,Cobb Rebecca¹,Fotheringham Susan¹,Harris Debbie¹,Kennard Chelsea¹,Leung Stephanie¹^ORCID,Ryan Kathryn¹^ORCID,Tolley Howard¹,Wand Nadina¹,White Andrew¹^ORCID,Sibley Laura¹^ORCID,Sarfas Charlotte¹^ORCID,Pearson Geoff¹,Rayner Emma¹,Xue Xiaochao²,Lambe Teresa³^ORCID,Charlton Sue¹,Gilbert Sarah³^ORCID,Sattentau Quentin J.²^ORCID,Gleeson Fergus⁴,Hall Yper¹^ORCID,Funnell Simon¹⁵,Sharpe Sally¹,Salguero Francisco J.¹,Gorringe Andrew¹^ORCID,Carroll Miles¹⁶^ORCID

Affiliation:

1. Public Health England, Porton Down, Salisbury SP4 0JG, UK.

2. The Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

3. The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.

4. Oxford Departments of Radiology and Nuclear Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.

5. Quadram Institute Bioscience, Norwich Research Park, Norfolk, UK.

6. Pandemic Preparedness Centre, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.

Abstract

No evidence of vaccine-enhanced disease was observed following inactivated SARS-CoV-2 vaccine in ferrets or rhesus macaques.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference64 articles.

1. Coronovirus Disease (2019) Weekly Epidemiological Update; www.who.int/docs/default-source/coronaviruse/situation-reports/20200824-weekly-epi-update.pdf?sfvrsn=806986d1_4.

2. Developing Covid-19 Vaccines at Pandemic Speed

3. Status Report on COVID-19 Vaccines Development

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Production and Immunogenicity Assessment of LTp50: An Escherichia coli-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein;Pharmaceuticals;2024-02-27

3. In vitro high-content tissue models to address precision medicine challenges;Molecular Aspects of Medicine;2023-06

4. Pre-clinical models to define correlates of protection for SARS-CoV-2;Frontiers in Immunology;2023-03-30

5. The emergence of SARS-CoV-2 lineages and associated antibody responses among asymptomatic individuals in a large university community;2023-02-01